logo

TRDA

Entrada Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
3.77 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Should I Buy TRDA Now?
  • Based on a composite score of 3.77/10, we rate TRDA as a Netural. Our analysis breaks down into 3.44/10 for Fundamentals, 3.94/10 for Technicals, and 3.85/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is TRDA fundamentally strong?
What is the current technical signals for TRDA?
What is the market sentiment for TRDA?